
The New Era of Targeted Therapy for Myasthenia Gravis
NeuroFrontiersThe New Era of Targeted Therapy for Myasthenia Gravis

Immunologic Phenotyping: The Future of Personalized MG Care
NeuroFrontiersImmunologic Phenotyping: The Future of Personalized MG Care

New Therapies, New Strategy: Rethinking MG Inpatient Care
NeuroFrontiersNew Therapies, New Strategy: Rethinking MG Inpatient Care

Navigating Emerging Treatment Options in MG
NeuroFrontiersNavigating Emerging Treatment Options in MG
- advertisement
- 3 questions
- advertisement

Taking Action in Friedreich Ataxia From Diagnosis to Treatment
Medical Industry FeatureTaking Action in Friedreich Ataxia From Diagnosis to Treatment

Centanafadine for Management of Executive Dysfunction and Emotional Dysregulation in Adults with ADHD
Innovations In MedicineCentanafadine for Management of Executive Dysfunction and Emotional Dysregulation in Adults with ADHD

Understanding CIDP: Disease Heterogeneity and Diagnostic Challenges
Medical Industry FeatureUnderstanding CIDP: Disease Heterogeneity and Diagnostic Challenges

Cerebral Organoid Model Transforms Glioblastoma Research
Medical Industry FeatureCerebral Organoid Model Transforms Glioblastoma Research

Understanding Sedation and Somnolence with Brexpiprazole in Agitation: What the Data Show
Innovations In MedicineUnderstanding Sedation and Somnolence with Brexpiprazole in Agitation: What the Data Show

Exploring the Role of IgG Autoantibodies in Idiopathic Inflammatory Myopathies (IIM)
Medical Industry FeatureExploring the Role of IgG Autoantibodies in Idiopathic Inflammatory Myopathies (IIM)
- 10/09/2026
- 10/09/2026
- 10/05/2026
- 10/01/2026
- 09/30/2026
- 09/30/2026









































